Th. P. Links

A Phase II Trial of Imatinib Therapy for Metastatic Medullary Thyroid Carcinoma

Jan Willem B. de Groot, Bernard A. Zonnenberg, Patricia Quarles van Ufford-Mannesse et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 180 citations

Medicine, Oncology, Pharmacology +12

Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer

Jan Willem B. de Groot, Th. P. Links, P.L. Jager et al. · Annals of Surgical Oncology · 2004 · 130 citations

Medicine, Nuclear Medicine, Oncology +16

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11

Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation

I Milos, Karin Frank‐Raue, Nelson Wohllk et al. · Endocrine Related Cancer · 2008 · 53 citations · Full text

Life Sciences, Endocrinology, Genetics +17

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial

T Schneider, Djoeke de Wit, Th. P. Links et al. · International Journal of Endocrinology · 2015 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17